Horizon Kinetics Asset Management LLC Bluebird Bio, Inc. Transaction History
Horizon Kinetics Asset Management LLC
- $6.03 Billion
- Q3 2024
A detailed history of Horizon Kinetics Asset Management LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 34,936 shares of BLUE stock, worth $11,179. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,936
Previous 36,468
4.2%
Holding current value
$11,179
Previous $35,000
48.57%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BLUE
# of Institutions
152Shares Held
63.7MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$4.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$3.35 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$1.5 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$1.49 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$1.23 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $24.7M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...